İzmir ilinde genç erişkinlerde metabolik sendrom prevalansı

In the study, metabolic syndrome was classified according to NCEP ATP III criterion on the basis of metabolic risk factors evaluated between December 2001 and April 2002.Results: The crude prevalence of metabolic syndrome (having three or more of the metabolic risk factors) was 3.6% among 20 and 29 years old men and 19.6% among 30 and 39 years old men and the increase by age was significant (p

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Objective: The aim of this study was to determine the prevalence of metabolic syndrome and its components among the young adult ages in İzmir, Turkey.Methods: A population-based cross-sectional study was held including 885 subjects aged between 20 to 39 years from 45 primary health care centres in Konak, which is the biggest urban area in İzmir.

📊

Key Findings & Data:A stratified sampling method was used to select the participants of 318 males and 567 females.

💡

Conclusion & Impact:In the study, metabolic syndrome was classified according to NCEP ATP III criterion on the basis of metabolic risk factors evaluated between December 2001 and April 2002.Results: The crude prevalence of metabolic syndrome (having three or more of the metabolic risk factors) was 3.6% among 20 and 29 years old men and 19.6% among 30 and 39 years old men and the increase by age was significant (p

🔬Design:Research Article

📍Scope:2001 Verileri

⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to determine the prevalence of metabolic syndrome and its components among the young adult ages in İzmir, Turkey.Methods: A population-based cross-sectional study was held including 885 subjects aged between 20 to 39 years from 45 primary health care centres in Konak, which is the biggest urban area in İzmir. A stratified sampling method was used to select the participants of 318 males and 567 females. In the study, metabolic syndrome was classified according to NCEP ATP III criterion on the basis of metabolic risk factors evaluated between December 2001 and April 2002.Results: The crude prevalence of metabolic syndrome (having three or more of the metabolic risk factors) was 3.6% among 20 and 29 years old men and 19.6% among 30 and 39 years old men and the increase by age was significant (p

Özet

Amaç: Çalışmamızda İzmir ili kentsel alanda genç erişkinler arasındaki metabolik sendrom prevalansını ve metabolik sendromun unsurlarını değerlendirdik.Yöntemler: Toplum bazlı, kesitsel çalışmaya İzmir’in en büyük ilçesi Konak’ta bulunan 45 sağlık ocağından 20-39 yaşları arasındaki 885 genç erişkin alındı: 318 erkek ve 567 kadından oluşan katılımcılar Aralık 2001 ve Nisan 2002 tarihleri arasında tabakalı örneklem yöntemi ile seçildi. Metabolik sendrom NCEP ATP III kriterlerine göre metabolik risk faktörleri temel alınarak değerlendirildi.Bulgular: Üç veya daha fazla metabolik risk faktörünün varlığında metabolik sendrom prevalansı 20-29 yaş grubu erkeklerde %3.6, 30-39 yaş grubu erkeklerde %19.6 bulundu ve yaşlanma ile görülen artış anlamlıydı (p

🔖

Cite This Article

KÖSEOĞLU, M., AKSAKOĞLU, G., UÇKU, R., SOYSAL, D., DEMİRAL, Y., SOYSAL, A. (2022). İzmir ilinde genç erişkinlerde metabolik sendrom prevalansı. Anadolu Kardiyoloji Dergisi, Cilt: 5 - Sayı: 3, 196–201. https://ajindex.com/articles/437359

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (11)

National Institutes of Health. Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III). Bethesda Md: National Institutes of Health
NIH Publication No.01-3670 2. Gotto AM, Amarenco P, Assmann G, et al. Rationale for control of dyslipidemia. Special populations “The Metabolic Syndrome”. In: International Lipid Information Bureau, editors. The ILIB Lipid Handbook for Clinical Practice-Dyslipidemia and Coronary Heart Disease. New York: International Lipid Information Bureau: 2003. p. 55-8 3. Onat A, Sansoy V. Halkıımızda koroner hastalığın baş suçlusu metabolik sendrom: Sıklığı, unsurları, koroner risk ile ilişkisi ve yüksek risk kriterleri. Türk Kardiyol Dern Arfl 2002
15 4. İzmir Konak Sağlık Grup Baflkanlığı, 2000 Yılı Çalışma Raporu. http://www.konaksgb.8k.com 5. World Health Organization: Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva, June, 1997 6. Guidelines Subcommittee, 1999 World Health Organization. International Society of Hypertension. Guidelines for the management of hypertension. J Hypertens 1999
46 7. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997
97 8. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of provisional. Report of a WHO Consultation. Diabet Met 1998
Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993
Mc Keique PM, Shah B, Marmot MG. Relationship of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991
Heseker H. An epidemiological study of food consumption hobits in Germany: comparison with other western countries. Medicographia 1994
Satman I, Yılmaz T, fiengül A, et al. Population-based study and risk characteristics in Turkey. Results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 2002
Knudsen P, Eriksson J, Lahdenpera S, et al., and the Botnia Study Group. Changes of lipolytic enzymes cluster with insulin resistance syndrome. Diabetologia 1995
Karlsson B, Knutsson A, Lindahl B. Is there an ass